Case Details for "Monogram Biosciences, Inc."

Investigation of the proposed acquisition of Monogram Biosciences, Inc.

Lawyers are investigating potential shareholder claims arising from the proposed acquisition of Monogram Biosciences, Inc. ("Monogram" or the "Company") (Nasdaq:MGRM) by Laboratory Corporation of America Holdings ("Labcorp") (NYSE:LH). Under the terms of the merger agreement, Monogram shareholders will receive $4.55 per share, for a total deal value of approximately $155 million.

The investigation is focused on the potential unfairness of the merger price and of the process by which the Monogram Board of Directors approved the agreement.

Posted on:06/24/2009
Company: Monogram Biosciences, Inc.
Affected Class: Current shareholders of Monogram Biosciences, Inc.
Scope: Nationwide

Contact Us Regarding This Investigation:

First Name
Last Name
Email Address
Phone Number
State of Residence	Please select Outside of US or Canada Canada Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Palau Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming
Name of Company At Issue
Description / Explanation
Security Code Please enter the code provided in the text box to submit this form.